On January 19th 1979 the company Interchemie werken "De Adelaar" B.V. was founded in Castenray, the Netherlands.

Initially, Interchemie traded in veterinary medicines in the Netherlands, Belgium and Germany. Due to rapidly increasing sales volumes and our customers' requirements to provide a complete range of veterinary products, it became necessary to establish a production facility.

Production facility
In 1983, to meet the increasing demand, the Interchemie production facility was established. The plant is divided into three production areas. Injectables, oral liquids and water-soluble powders are produced according to the G.M.P. regulations. The company is equipped with a professional laboratory, staffed by highly qualified personnel to ensure quality control from incoming goods through to finished products.

Research and development
Research and development form an essential role in the company's strategic growth. Its scientific staff has developed a complete range of veterinary products. These include high quality injectable preparations, water-soluble powders and an extensive range of oral liquids.

Serving customers worldwide
From its well established domestic sales base, Interchemie started an export drive in 1988, which has resulted in extensive global commercialisation of the veterinary range of products. The existing customer base extends throughout Europe, Latin America, the Far East, the Middle East and Africa.

Registration laboratory
Due to the registration regulations in the Netherlands, all products have to be registered with the Ministry of Agriculture. In recognition of the increasing regulatory requirements, Interchemie established its own registration laboratory in 1991 to conduct in house research on residues, withdrawal times, bloodlevels and product stability. This resulted in many registrations in the Netherlands.

Strategy
The resultant registration dossiers have complemented the export drive and facilitated the registration of Interchemie products worldwide. During the development and growth of the company the strategy remains the same. To develop, produce, register and market the high quality range of products on a worldwide basis.

Castenray, 1 November 2007

M.P.J. Gellings
General director